This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kiraz, S Articles by Kirazlil, S Search for Related Content PubMed PubMed Citation Articles by Kiraz, S Articles by Kirazlil, S Social Bookmarking                         What's this?

Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state

Department of Internal Medicine, Hacettepe University, Ankara, Turkey

Ertenli

M Benekli

C Haznedaroul

M Çalgüneri

Çelik

Apra

Kirazlil

Department of Internal Medicine, Hacettepe University, Ankara, Turkey

Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder with overwhelming thrombotic states. The precise pathogenetic mechanisms underlying the prethrombotic state in SLE is not filly understood, but interactions between the antiphospholipid antibodies and antigen targets on the coagulation components have been incriminated to play fundamental roles. To evaluate this issue, 34 women with antiphospholipid antibody negative SLE were investigated for molecular markers of blood coagulation and fibrinolytic activity: prothrombin fragmentl+₂ (PF1 +2), thrombin-antithrombin complex (TAT), plasmin--a2-antiplasmin inhibitor complex (PAP), and tissue factor pathway inhibitor (TFPI). We also analysed plasma soluble thrombomodulin (sTM) levels. SLE disease activity was determined using the SLE Disease Activity Index (SLEDAI). Concentrations of TAT, PAP, PFl + 2 and sTM were significantly elevated (P < 0.0001, P = 0.0002, P < 0.0001, and P < 0.0001, respectively), while TFPI antigen levels were found to be reduced (P < 0.0001) in patients with SLE compared to the control group. In patients with active SLE, anti-ds DNA levels were correlated positively with plasma TAT (P < 0.05), PFl + 2 (P < 0.05), and sTM (P < 0.01) concentrations and negatively with plasma TFPI levels (P < 0.05). SLEDAI scores were correlated positively with plasma TAT (P < 0.01), PFl + 2 (< 0.01), and sTM (P < 0.01) levels. This study illustrates that both a prethrombotic state and a compensatory fibrinolytic process secondary to subclinical intravascular coagulation might coexist in SLE with elevated sTM levels, indicating impaired endothelial functions.

Key Words: systemic lupus erythematosus • hemostasis • thrombosis • coagulation • fibrinolysis • thrombomodulin

Lupus, Vol. 8, No. 9, 737-741 (1999)
DOI: 10.1191/096120399678840918


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Yao, Z. Liu, X Zhang, C. Zheng, H. Chen, C. Zeng, and L. Li Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis Lupus, August 1, 2008; 17(8): 720 - 726. [Abstract] [PDF]

				M. Erman, H. Abali, B. Oran, I. C. Haznedaroglu, H. Canpinar, S. Kirazli, and I. Celik Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state? Ann. Onc., November 1, 2004; 15(11): 1622 - 1626. [Abstract] [Full Text] [PDF]

				D Barcat, V Guerin, A Ryman, J Constans, J P Vernhes, C Vergnes, F Bonnet, X Delbrel, P Morlat, M Longy-Boursier, et al. Thrombophilia and thrombosis in systemic lupus erythematosus: a case-control study Ann Rheum Dis, October 1, 2003; 62(10): 1016 - 1017. [Full Text]

				C. Y. Ho, C. K. Wong, E. K. Li, L. S. Tam, and C. W. K. Lam Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus Rheumatology, January 1, 2003; 42(1): 117 - 122. [Abstract] [Full Text] [PDF]